“ Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency ”, Clinics, vol. 66, no. 8, pp. 1361–1366, Jan. 2011, doi: 10.1590/S1807-59322011000800009.